Acquired Amegakaryocytic Thrombocytopenia Overview

Save information for later
Sign Up

Learn About Acquired Amegakaryocytic Thrombocytopenia

Who are the top Acquired Amegakaryocytic Thrombocytopenia Local Doctors?
Elite in Acquired Amegakaryocytic Thrombocytopenia
Elite in Acquired Amegakaryocytic Thrombocytopenia
Carl Neuberg Str. 1, 
Hannover, NI, DE 

Manuela Germeshausen practices in Hannover, Germany. Ms. Germeshausen is rated as an Elite expert by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. Her top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Agranulocytosis, Cyclic Neutropenia, and Severe Congenital Neutropenia.

Elite in Acquired Amegakaryocytic Thrombocytopenia
Elite in Acquired Amegakaryocytic Thrombocytopenia
Carl Neuberg Str. 1, 
Hannover, NI, DE 

Matthias Ballmaier practices in Hannover, Germany. Mr. Ballmaier is rated as an Elite expert by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. His top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Thrombocytopenia, Aplastic Anemia, and Paroxysmal Cold Hemoglobinuria.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Acquired Amegakaryocytic Thrombocytopenia
Pediatric Hematology Oncology
Elite in Acquired Amegakaryocytic Thrombocytopenia
Pediatric Hematology Oncology
1601 Center St, 
Mobile, AL 
Languages Spoken:
English

Preethi Marri is a Pediatric Hematologist Oncology provider in Mobile, Alabama. Dr. Marri is rated as an Elite provider by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. Her top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Renal Vein Thrombosis, Sickle Cell Disease, Mesenteric Venous Thrombosis, and Bone Marrow Transplant.

What are the latest Acquired Amegakaryocytic Thrombocytopenia Clinical Trials?
A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults ≤55 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation

Summary: The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched unrelated donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders that are amenable to treatment with hematopoietic stem cell transplant (HSCT). ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Allogeneic Stem Cell Transplantation for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion - NYMC 588

Summary: Children, adolescents, and young adults with malignant and non-malignant conditionsundergoing an allogeneic stem cell transplantation (AlloSCT) will have the stem cells selected utilizing α/β CD3+/CD19+ cell depletion. All other treatment is standard of care.

Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center